Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD

Xun Liu1, Meredith C Foster2, Hocine Tighiouart2

  • 1Division of Nephrology, Department of Internal Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Guanghzou, China.

Insights

Serum levels of β-trace protein (BTP), β2-microglobulin (B2M), and cystatin C are influenced by factors beyond glomerular filtration rate (GFR). Understanding these influences improves GFR estimation and risk assessment.

Area of Science:

  • Nephrology
  • Biomarker Discovery
  • Renal Physiology

Background:

  • Determinants of serum levels for low-molecular-weight proteins like β-trace protein (BTP), β2-microglobulin (B2M), and cystatin C, independent of glomerular filtration rate (GFR), are not well understood.
  • Creatinine, a common GFR marker, is affected by non-GFR factors, but similar characterization for other markers is lacking.

Purpose of the Study:

  • To investigate and characterize the non-GFR determinants of serum BTP, B2M, and cystatin C levels in individuals with chronic kidney disease.
  • To compare the associations of these non-GFR determinants with BTP, B2M, and cystatin C versus serum creatinine.

Main Methods:

  • Pooled cross-sectional analysis of 3,156 participants from the Modification of Diet in Renal Disease (MDRD) Study, African American Study of Kidney Disease and Hypertension (AASK), and Chronic Renal Insufficiency Cohort (CRIC) Study.
  • Utilized multivariable-adjusted errors-in-variables regression models, accounting for measured GFR (mGFR) and its measurement error.
  • Examined demographic (sex, race, age) and clinical factors (urine creatinine excretion, urine protein excretion, weight, smoking) as potential predictors.

Main Results:

  • Serum creatinine showed stronger associations with male sex, black race, and higher urine creatinine excretion compared to BTP, B2M, and cystatin C.
  • BTP, B2M, and cystatin C exhibited different associations with age, sex, and race compared to creatinine.
  • BTP, B2M, and cystatin C levels were more strongly associated with factors like urine protein excretion, weight, and smoking than creatinine.

Conclusions:

  • Serum levels of low-molecular-weight proteins (BTP, B2M, cystatin C) are influenced by various non-GFR factors, similar to creatinine.
  • Understanding these non-GFR determinants is crucial for accurate interpretation of GFR estimates and risk stratification using these markers.
  • Findings may not generalize to populations without chronic kidney disease, and residual confounding with GFR is possible.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
88
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
287
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
538
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
574
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
952
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
578